BioWorld. Link to homepage.
BioWorld
BioWorld MedTech
BioWorld Asia
BioWorld Science
Data Snapshots
BioWorld
BioWorld MedTech
Infographics: Dynamic digital data analysis
Special reports
Infographics: Dynamic digital data analysis
Trump administration impacts
Biopharma M&A scorecard
BioWorld 2024 review
BioWorld MedTech 2024 review
BioWorld Science 2024 review
Women's health
China's GLP-1 landscape
PFA re-energizes afib market
China CAR T
Alzheimer's disease
Israel
Rise of obesity
Radiopharmaceuticals
Biosimilars
Aging
IVDs on the rise
Coronavirus
Artificial intelligence
BioWorld. Link to homepage.
Sign In
Sign Out
My Account
Subscribe
BioWorld - Friday, March 7, 2025
Home
»
Newsletters
» BioWorld
BioWorld
Jan. 15, 2009
View Archived Issues
Genzyme Reports Strong Quarter Despite Hit from Exchange Rate
Read More
NewCo News: Satori Names New CEO, Hauls in $22M for Alzheimer's Candidates
Read More
Finding the Money with BioWorld's VC Directory
Read More
Clinic Roundup
Read More
Other News To Note
Read More
Cephalon Pays $100M Up Front for Option to Buy Ception
Cephalon Inc. left its comfort zone of cancer and pain, giving Ception Inc. a $100 million up-front payment for an option to buy the company and its main anti-inflammatory product for an additional $250 million-plus. (BioWorld Today)
Read More
